Bristol-Myers partners with Johns Hopkins on Opdivo pact; A Valeant by any other name…
Johns Hopkins scientists will go to work studying Bristol-Myers Squibb’s Opdivo and Yervoy, looking for their weak points as the company looks to improve …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
